J Korean Med Sci.  2019 Jul;34(28):e197. 10.3346/jkms.2019.34.e197.

The Anti-Inflammatory Effect of Sulforaphane in Mice with Experimental Autoimmune Encephalomyelitis

Affiliations
  • 1Department of Neurology, Chung-Ang University Hospital, Chung-Ang University College of Medicine, Seoul, Korea. icandr@cau.ac.kr
  • 2Center for Food and Bioconvergence, College of Agriculture and Life Sciences, Seoul National University, Seoul, Korea.
  • 3Department of Neurology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea.
  • 4Department of Obstetrics and Gynecology, Hallym University Kangnam Sacred Heart Hospital, Hallym University College of Medicine, Seoul, Korea.

Abstract

BACKGROUND
Multiple sclerosis (MS) is an immune-associated inflammatory disorder of the central nervous system and results in serious disability. Although many disease-modifying therapy drugs have been developed, these drugs have shown limited clinical efficacy and some adverse effects in previous studies, therefore, there has been reasonable need for less harmful and cost-effective therapeutics. Herein, we tested the anti-inflammatory effect of sulforaphane (SFN) in a mouse model of experimental autoimmune encephalomyelitis (EAE).
METHODS
The EAE mice were randomly assigned into two experimental groups: the phosphate-buffered saline (PBS)-treated EAE group and SFN-treated EAE group. After EAE mice induction by auto-immunization against the myelin oligodendrocyte glycoprotein peptide, we evaluated EAE symptom scores and biochemical analyses such as infiltration of inflammatory cells and demyelination of the spinal cord. Furthermore, western blotting was performed using the spinal cords of EAE mice.
RESULTS
In the behavioral study, the SFN-treated EAE mice showed favorable clinical scores compared with PBS-treated EAE mice at the 13th day (1.30 ± 0.15 vs. 1.90 ± 0.18; P = 0.043) and 14th day (1.80 ± 0.13 vs. 2.75 ± 0.17; P = 0.003). Additionally, the biochemical studies revealed that SFN treatment inhibited the inflammatory infiltration, demyelinating injury of the spinal cords, and the up-regulation of inducible nitric oxide synthase in the EAE mice.
CONCLUSION
The SFN treatment showed anti-inflammatory and anti-oxidative effects in the EAE mice. Conclusively, this study suggests that SFN has neuroprotective effects via anti-inflammatory processing, so it could be a new therapeutic or nutritional supplement for MS.

Keyword

Multiple Sclerosis; Experimental Autoimmune Encephalomyelitis; Sulforaphane; Neuromyelitis Optica; Phytochemical

MeSH Terms

Animals
Blotting, Western
Central Nervous System
Demyelinating Diseases
Encephalomyelitis, Autoimmune, Experimental*
Mice*
Multiple Sclerosis
Myelin-Oligodendrocyte Glycoprotein
Neuromyelitis Optica
Neuroprotective Agents
Nitric Oxide Synthase Type II
Spinal Cord
Treatment Outcome
Up-Regulation
Myelin-Oligodendrocyte Glycoprotein
Neuroprotective Agents
Nitric Oxide Synthase Type II
Full Text Links
  • JKMS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr